ID: ALA5171913

Chembl Id: CHEMBL5171913

PubChem CID: 168270628

Max Phase: Preclinical

Molecular Formula: C199H270N58O49S4

Molecular Weight: 4386.97

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CSSCCOC(=O)O[C@]1(CC)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1)C(=O)NCC(=O)N[C@@H](CSSCCOC(=O)O[C@]1(CC)C(=O)OCC2=C1C=C1c3nc4ccccc4cc3NC1C2=O)C(=O)NC(=O)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O

Standard InChI:  InChI=1S/C199H270N58O49S4/c1-6-102(4)158(253-165(273)121(204)39-26-66-219-191(209)210)184(292)244-133(46-22-25-65-202)187(295)255-71-31-51-146(255)182(290)242-131(50-30-70-223-195(217)218)171(279)239-127(45-21-24-64-201)166(274)226-93-155(268)231-135(78-105-53-57-112(260)58-54-105)179(287)254-159(103(5)259)185(293)243-128(47-27-67-220-192(211)212)167(275)227-94-156(269)233-144(100-309-307-75-73-302-197(300)306-199(8-3)120-85-148-160-111(80-107-35-12-16-40-122(107)235-160)96-257(148)186(294)118(120)99-304-190(199)298)169(277)229-95-157(270)234-145(101-310-308-76-74-301-196(299)305-198(7-2)119-84-116-161-134(81-108-36-13-17-41-123(108)236-161)237-162(116)163(271)117(119)98-303-189(198)297)181(289)252-152(265)88-142(232-153(266)89-203)188(296)256-72-32-52-147(256)183(291)250-141(87-151(207)264)178(286)247-138(82-109-90-224-124-42-18-14-37-114(109)124)168(276)228-92-154(267)230-129(48-28-68-221-193(213)214)170(278)251-143(97-258)180(288)248-139(83-110-91-225-125-43-19-15-38-115(110)125)176(284)246-137(79-106-55-59-113(261)60-56-106)175(283)249-140(86-150(206)263)177(285)241-132(61-62-149(205)262)173(281)240-130(49-29-69-222-194(215)216)172(280)245-136(77-104-33-10-9-11-34-104)174(282)238-126(164(208)272)44-20-23-63-200/h9-19,33-38,40-43,53-60,80-81,84-85,90-91,102-103,121,126-133,135-147,158-159,162,224-225,237,258-261H,6-8,20-32,39,44-52,61-79,82-83,86-89,92-101,200-204H2,1-5H3,(H2,205,262)(H2,206,263)(H2,207,264)(H2,208,272)(H,226,274)(H,227,275)(H,228,276)(H,229,277)(H,230,267)(H,231,268)(H,232,266)(H,233,269)(H,234,270)(H,238,282)(H,239,279)(H,240,281)(H,241,285)(H,242,290)(H,243,293)(H,244,292)(H,245,280)(H,246,284)(H,247,286)(H,248,288)(H,249,283)(H,250,291)(H,251,278)(H,253,273)(H,254,287)(H4,209,210,219)(H4,211,212,220)(H4,213,214,221)(H4,215,216,222)(H4,217,218,223)(H,252,265,289)/t102-,103+,121-,126-,127-,128-,129-,130-,131-,132-,133-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,158-,159-,162?,198-,199-/m0/s1

Standard InChI Key:  UMVXQFGEAIVASF-NQKQSBNWSA-N

Alternative Forms

  1. Parent:

    ALA5171913

    ---

Associated Targets(Human)

SK-BR-3 (5175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-N87 (850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-OV-3 (52876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF-10A (2462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP1 Tclin DNA topoisomerase I (7553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Epidermal growth factor receptor and ErbB2 (HER1 and HER2) (186 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 4386.97Molecular Weight (Monoisotopic): 4383.9302AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Zhou J, Bian X, Kan Z, Cai Z, Jiang Y, Wang Z, Li Y, Shi W, Qian H..  (2022)  In Silico Exploration and Biological Evaluation of Bispecific Peptides Derived from Anti-HER2 Antibodies and Peptide-Camptothecin Conjugates for HER2-Positive Breast Cancer.,  65  (22.0): [PMID:36351049] [10.1021/acs.jmedchem.2c00968]

Source